Eligibility Matcher
Select your organization type below to see only the grants you qualify for — sorted by soonest deadline.
415 grants for Nonprofits without 501(c)(3) status
Sorted by deadline (soonest first)
OJJDP FY 2026 Multistate Mentoring Programs
USDOJ-OJP-OJJDP · O-OJJDP-2026-172745
OJJDP FY 2026 Community and Schools Youth Drug Prevention Program
USDOJ-OJP-OJJDP · O-OJJDP-2026-172734
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
HHS-NIH11 · RFA-HG-27-012
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
HHS-NIH11 · RFA-HG-27-013
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
HHS-NIH11 · RFA-HG-27-011
BJA FY 2026 National Center for Veterans Justice
USDOJ-OJP-BJA · O-BJA-2026-172760
BJA FY 2026 Students, Teachers, and Officers Preventing (STOP) School Violence Program
USDOJ-OJP-BJA · O-BJA-2026-172709
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)
HHS-NIH11 · PAR-27-045
BJA FY 2026 Second Chance Act Community-based Reentry Program
USDOJ-OJP-BJA · O-BJA-2026-172717
Small Business Transportation Technical Assistance Center (Region 3)
DOT-OSDBU · OST-OSDBU-2027-SBTTAC-REGION3-FY2027-1
Small Business Transportation Technical Assistance Center (Region 1)
DOT-OSDBU · OST-OSDBU-2027-SBTTAC-REGION1-FY2027-1
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-24-280
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
HHS-NIH11 · PAR-24-279
BJA FY 2026 Upholding the Rule of Law and Preventing Wrongful Convictions Program
USDOJ-OJP-BJA · O-BJA-2026-172726
BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) Training and Technical Assistance (TTA)
USDOJ-OJP-BJA · O-BJA-2026-172724
OJJDP FY 2026 Second Chance Act Youth Reentry Program
USDOJ-OJP-OJJDP · O-OJJDP-2026-172751
Exploring and Enhancing Outdoor and Heritage Tourism in the Chesapeake Bay Watershed
DOI-NPS · P27AS00032
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-255
Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
HHS-CDC-HHSCDCERA · RFA-CK-26-035
US Travelers Health Research, Surveillance, Communication, and Outreach Network
HHS-CDC-HHSCDCERA · RFA-CK-26-036
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-095
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
HHS-NIH11 · RFA-NS-26-001
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-CA-27-002
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-CA-27-001
Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)
HHS-NIH11 · RFA-OD-27-009